Skip to content

RECOVERY OF MICROVASCULAR MYOCARDIAL RESISTANCE AFTER ST ELEVATION MYOCARDIAL INFARCTION AND ITS RELATION TO OUTCOME

RECOVERY OF MICROVASCULAR MYOCARDIAL RESISTANCE AFTER ST ELEVATION MYOCARDIAL INFARCTION AND ITS RELATION TO OUTCOME - microvascular resistance STEMI study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44383
Enrollment
50
Registered
2018-03-16
Start date
2018-11-26
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute myocardial infarction

Interventions

None listed

Sponsors

Catharina-ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Patients with STEMI * 12 hours and with ST deviation * 5 mm. Who have one or more other lesions mandating FFR or PCI in de following days after PCI of the culprit artery;INCLUSION CRITERIA * Age between 18 and 75 years * Presentation within 12 hours after the onset of complaints * Acute ST-elevation myocardial infarction with a total ST segment deviation *5 mm * Able to give and understand informed consent * Culprit lesion in a proximal or mid-segment of one of the major coronary arteries (diameter *2,5 mm), which is stented successfully * Stable condition after stenting * One or more additional lesions in one or more different coronary arteries, mandating FFR measurement +/- PPCI during the subacute phase

Exclusion criteria

Exclusion criteria: * Age less than 18 years or more than 75 years * Cardiogenic shock or pre-shock * Patients with previous myocardial infarction in the culprit artery or with previous bypass surgery * Very tortuous or calcified coronary arteries * Long or complex PCI * Severe concomitant disease or conditions with a life expectancy of less than 1 year * Inability to understand and give informed consent * Known myocardial diseases such as moderate or severe left ventricular hypertrophy or cardiomyopathy * Pregnancy * Severe conduction disturbances necessitating implantation of a temporary pacemaker * Contraindications for MRI (claustrophobia, ferromagnetic metal fragments in the body)

Design outcomes

Primary

MeasureTime frame
evaluate changes in myocardial resistance over time in STEMI patients, both in the early stage and the subacute phase. It is hypothesized that patients can be divided into 3 groups: A. Patients with an (almost) normal resistance and flow immediately after PPCI B. Patients with still elevated resistance and decreased flow immediately after PPCI, but (partial) recovery in the next days C. Patients with elevated resistance and decreased flow immediately after PPCI which do not recover at all.

Secondary

MeasureTime frame
The course of such changes and recovery of the microcirculation will be correlated to long-term outcome as assessed by MRI measurements and final infarct size 1) Long term outcome 2) final infarct size on MRI

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)